Devon Park Bioventures is a private equity general partner firm headquartered in Wayne, PA, United States.
UK drugmaker AstraZeneca has agreed to pay $2.7bn in cash for ZS Pharma, a VC-backed biopharmaceutical company.
Inotek Pharmaceuticals, a VC-backed biopharmaceutical firm focused on developing treatments for glaucoma, has debuted its IPO.
Proteon Therapeutics has raised $45m from Abingworth, TVM Capital, Prism VentureWorks, Skyline Ventures, Intersouth Partners and others.
Read more news concerning Devon Park Bioventures
A sampling of Devon Park Bioventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?